Skip to content

The Acute T-Rex (Timing of Resistance Exercise) Study

Timing (AM v PM) of Acute Resistance Exercise on Glycemic Control in Older Adults: The Acute T-Rex Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06366399
Enrollment
20
Registered
2024-04-15
Start date
2023-11-15
Completion date
2025-12-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Glucose Intolerance, Insulin Resistance, Insulin Sensitivity, Overweight or Obesity, Sleep Disturbance

Keywords

Resistance Exercise, Strength-training, Sleep, Circadian Rhythm

Brief summary

The primary aim of this study is to evaluate if a single bout of AM vs PM resistance exercise has different effects on insulin sensitivity and sleep. A randomized cross-over trial be used to compare resistance exercise at two different times of the day. Each condition will take place in a laboratory setting. Each condition will consist of exercise, overnight sleep, and oral glucose tolerance tests the following day. The AM exercise will occur \ 1.5 hours after habitual wake, and PM exercise will occur \ 11 hours after habitual wake. After a 2-6 week washout, participants will complete the other condition. The hypothesis is that PM exercise will be more beneficial than AM exercise in improving insulin sensitivity. This study could identify if there is a better time of day to perform resistance exercise to decrease risk of developing Type 2 Diabetes Mellitus.

Interventions

BEHAVIORALResistance Exercise Timing

1 resistance exercise session consisting of 3 sets, 10 repetitions per set, on 12 different exercises

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Men and women, all ethnicities, aged 50-74 years * BMI ≥25 kg/m² and \<45 kg/m² * Weight stable (less than 5% change in the past 6 months) * Generally healthy individuals * Not meeting recommended activity guidelines for aerobic or resistance exercise

Exclusion criteria

* Uncontrolled cardiovascular, metabolic, renal, or pulmonary disease * Cancer treatment in the past 5 years * Untreated thyroid disease or other medical conditions affecting weight or energy metabolism * Current use of weight loss medication or other medications likely to impact energy balance * Bariatric surgery or extensive bowel resection in the past 2 years * Current or recent history (past 2 years) of eating disorder * Diagnosis of insomnia, sleep apnea, or other sleep and circadian disorders * Non-English speaking * HbA1c \>6.5%

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivity1 dayInsulin sensitivity will be calculated using the Matsuda Insulin Sensitivity Index

Secondary

MeasureTime frameDescription
Sleep Duration1 daySum of time spent in stage 1, stage 2, stage 3 and rapid eye movement stage (REM) as assessed via polysomnography.

Other

MeasureTime frameDescription
Sleep Efficiency1 dayRatio of time in bed vs time asleep
Muscular Strength1 dayMuscular strength as assessed via 10 repetition maximum test
Perceived Hunger1 dayVisual Analog Scales (scale: 0-100)
Sleep Staging1 dayTime spent in stage 1, stage 2, stage 3 and REM sleep assessed by polysomnography.
Perceived Prospective Food Consumption1 dayVisual Analog Scales (scale: 0-100)
Glucose Area Under Curve1 dayMathematical calculation using fasting, 10,20,30,60,90,120 min blood glucose
Insulin Area Under Curve1 dayMathematical calculation using fasting, 10,20,30,60,90,120 min blood insulin
Perceived Fullness1 dayVisual Analog Scales (scale: 0-100)
Sleep Quality1 dayAs assessed via Pittsburg Sleep Quality Index Questionnaire (scale:0-21, higher scores=worse outcome) and polysomnography

Countries

United States

Contacts

Primary ContactTanya M Halliday, PhD
tanya.halliday@utah.edu801-213-1364
Backup ContactStudy Email Study Email
trexstudy@utah.edu8014487897

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026